A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males

Phase 3 Completed 160 enrolled Ferring Pharmaceuticals

NaSingle-groupOpen-labelTreatment

Summary

This is a phase 3, open-label, non-randomized, clinical trial to evaluate the efficacy and safety of FE 999303 (Testosterone gel) in adult hypogonadal males.

Timeline

Start: 2014-07
Primary completion: 2015-05
Completion: 2015-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Testosterone	Small molecule	23 mg	Topical

A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males

Summary

Timeline

Drugs

Indications